Indefinite Delivery Contract SPE2D221D0135
Award Date
6/28/21
Last Date to Order
6/27/26
Federal Agency
Medical Supply Chain
Awardee
Exelan Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The single-award IDC, valued at up to $6,984,109.81, has an ultimate completion date of February 11, 2029. Under this contract, Exelan Pharmaceuticals will provide a variety of generic pharmaceutical products to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The $29,031,544.57 IDC covers the delivery of a wide range of branded and generic pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service through August 2029. Key items include medications such as ibuprofen, citalopram, albuterol,...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award, unrestricted Indefinite Delivery Contract (IDC) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract, valued at a ceiling of $48,442,917.75, is for the supply of Escitalopram Oxalate Tablets in various package sizes to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted IDC has a ceiling value of $4,792,297.44 and a period of performance through December 19, 2025. The contract covers the delivery of a variety of generic pharmaceutical products, including Dofetilide Capsules, to the VA, Department of...
This Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $10,379,933.80 and a period of performance from October 27, 2022 to October 26, 2025, with four one-year option periods. The contract is for the delivery of Sildenafil Citrate tablets in various strengths and package sizes to support the medication needs of the...
This Indefinite Delivery Contract, awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., provides for the delivery of Zonisamide capsules in various dosages to the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The single-award, firm fixed-price contract has a period of performance from June 15, 2021 to June 14, 2022, with four one-year option periods, for a total ceiling value of $8,974,952.04....
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract has a ceiling value of $40,480,225.15 and a period of performance from February 12, 2022 to February 11, 2023, with four one-year option periods. The contract was awarded to provide an uninterrupted supply of various strengths and package sizes of...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company that specializes in providing branded and generic medications to U.S. government agencies. The $5.59 million contract, with a performance period from June 2021 to June 2026, is to manufacture and distribute alendronate sodium tablets in 35mg and 70mg dosages for purchase by the Department of Defense (DoD) and Department of...
The federal contract IDV award SPE2D219D0070 was granted to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The IDV is a single-award indefinite delivery contract with a ceiling value of $45,158,494.05 and an ultimate completion date of May 28, 2024. Exelan Pharmaceuticals, a key supplier of generic and branded pharmaceutical products to various federal healthcare agencies, will deliver a diverse range of pharmaceutical items...
This single-award Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The IDC has a ceiling value of $7,656,786.70 and a period of performance from June 3, 2025 to June 2, 2026, with four one-year option periods. The contract primarily consists of 6 line items for the delivery of Cyclobenzaprine HCL Tablets in various package sizes, including 30,...